
Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers. Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State College of Medicine study. “The public often hears that the… read on > read on >